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Leg ulceration in drug users: 
development of a multidisciplinary 
care pathway
Leanne Cook, Karen Jordon
Leanne Cook is Vascular Specialist at Mid Yorkshire NHS 
Trust and Lecturer Practitioner at the University of 
Huddersfield; Karen Jordon is Lead Well-being Nurse, 
Wakefield Integrated Substance Misuse Service, Wakefield
Individuals with a history of intravenous (IV) drug abuse can develop a degree of venous insufficiency either 
through the damage of veins from the injection, or the formation of deep vein thrombosis (DVT), a complication 
of IV drug abuse. Long-term venous insufficiency can result in painful lower limb ulceration that can negatively 
effect quality of life. This patient group can be challenging to manage due to problems with engagement and 
concordance; patients often have chaotic lifestyles with a range of health needs. A care pathway was developed to 
promote healing through the implementation of the well-being model and utilisation of the multidisciplinary team. 
Leg ulceration is a chronic condition affecting approximately 1–2 % of the population (Nelzen 
et al, 1991; Briggs and Closs, 2003; 
Graham et al, 2003; Vowden and 
Vowden, 2009), with venous leg 
ulceration being the most prevalent 
of chronic wounds in the Western 
world, accounting for 45–60% of all 
chronic leg ulcers (Mekkes et al, 2003). 
Leg ulceration imposes a significant 
financial burden on the NHS. It is 
estimated that on any day between 
70,000 and 190,000 people may have 
an active leg ulcer in the UK, with 
the total annual cost of treatment 
lying between £168 and £198 million 
(Posnett and Franks, 2007). The cost 
to the NHS of caring for patients with 
for England suggesting that there were 
around 117,000 injectors of heroin or 
crack cocaine in 2006 (0.34% of those 
aged 15–64) (Hay et al, 2008). While 
other studies (Hickman et al, 2004; De 
Angelis et al, 2009) have suggested that 
the total number of IV drug users in 
England may be much higher, the most 
recent publication from the National 
Treatment Agency (2010) has reported 
that the number of IV heroin users in 
England has fallen by almost 11,000, an 
encouraging trend.
Patients with a history of IV 
drug use have many risk factors for 
developing chronic venous insufficiency 
due to damage of superficial veins 
through repeated trauma and 
thrombophlebitis. In addition, deep 
venous damage can occur as a result 
of deep vein thrombosis (DVT). 
Pieper and Templin (2001) identified 
DVT as being a common occurrence 
in IV drug users, and also reported 
that 87% of patients in a methadone 
treatment programme were found 
to have evidence of chronic venous 
insufficiency. It has been recognised 
that chronic venous insufficiency and 
subsequent venous hypertension are 
the main causative factors for the 
development of venous ulceration, 
(Mekkes et al, 2003; Anderson, 2008; 
O’Meara et al, 2009).
In addition to venous insufficiency, 
skin problems can be the result of 
??
Clinical PRACTICE DEVELOPMENT
Wounds uk, 2010, Vol 6, No 4
KEY WORDS
Leg ulceration
Intravenous drug users 
Well-being model  
Care pathway 
Multidisciplinary working  
a chronic wound is conservatively 
estimated at £2.3bn–3.1bn per year 
(at 2005–2006 costs), around 3% of 
the total estimated expenditure on 
health (£89.4bn) for the same period 
(Posnett and Franks, 2007).
Patients with a history of 
IV drug use have many 
risk factors for developing 
chronic venous insufficiency 
due to damage of 
superficial veins through 
repeated trauma and 
thrombophlebitis. 
The population most commonly 
affected by leg ulceration are those 
aged over 65 (3–5% in population over 
65 years of age ) (Mekkes et al, 2003). 
In addition, leg ulceration is known to 
be a consequence of intravenous (IV) 
drug use. Most drug users in the UK are 
young people aged 15–44 years (Finnie 
and Nicholson, 2003). The Department 
of Health (DH, 2007) stated that the 
United Kingdom(UK) has among the 
highest rates of recorded illegal drug 
misuse in the western world, and 
identify Scotland and England as having 
higher rates than Wales and Northern 
Island. The true extent of injecting 
drug use in the UK remains uncertain 
(Health Protection Agency [HPA], 
2009), with a recent national estimate 
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injection behaviour, the quality, solvency 
and cleanliness of drugs, the equipment 
and the environment (Finnie and 
Nicolson, 2002). When venous access 
becomes a problem due to superficial 
veins becoming thrombosed, many 
users resort to skin popping, which 
is where the substance is deposited 
under the skin and absorbed by 
the subcutaneous tissue (Finnie and 
Nicolson, 2002). This approach can 
lead to abscess formation, infection 
and frequent scaring (Finnie and 
Nicolson, 2002). Around one-third 
of users report an injection-related 
abscess, sore or open wound within 
a one-year period (Health Protection 
Agency [HPA], 2009). This is not 
surprising as heroin is not a sterile 
drug, but is often mixed with citric acid, 
which, if over used, can contribute to 
acid burns either within the vessels 
or the subcutaneous tissues leading 
to cell death and necrosis (Finnie and 
Nicolson, 2003). Moreover, heroin is 
often produced in filthy conditions and 
injected in unhygienic circumstances 
(Finnie and Nicolson, 2003). Harm 
reduction initiatives, including needle 
exchange programmes, safer injection 
facilities and provision of mixing powers 
can reduce the incidence of infections 
among IV drug users (Bassetti and 
Battegay, 2004; Roden, 2009).
Drug users have a wider range of 
health problems (Neale, 2004) and a 
higher rate of mental health disorders 
than the general population. Weaver et 
al (2002) identified that in the UK, 75% 
of users of drug services experienced 
mental health problems, the most 
common of these being depression 
and anxiety disorders. Furthermore, 
Gossop et al (2002) maintained that 
the annual mortality rate among users 
in treatment in the UK was about six 
times higher than that for a general, 
age-matched population. 
Often dependency to a substance 
dominates patients’ lives and can place 
an enormous strain on their family, 
including their children. This can have 
a serious negative impact on the long-
term health and well-being of family 
members (DH, 2007). The ‘Hidden 
Harm’ report published by the Advisory 
Council on the Misuse of Drugs 
(ACMD, 2003) estimated that there 
were between 250,000 and 350,000 
children of problem drug misusers in 
the UK. The report stated that parental 
problem drug misuse can and does 
cause serious harm to children at every 
age, and that reducing harm to children 
from parental problem drug misuse 
should become a main objective of 
incorporates all aspects of health and 
well-being. 
Role of well-being nurses 
Well-being nurses are ideally placed 
to ensure that opportunities are 
not missed to initiate healthcare 
interventions. These include 
treatment of acute episodes of illness, 
immunisations, counselling, blood 
virus testing, health promotion, harm 
reduction initiatives and safer injection 
techniques. It is also important 
to remember that the drug user 
population are at risk from all diseases 
(DH, 2007) and should be included 
in health screening programmes and 
health assessments. However, due to 
their often chaotic lifestyles, users can 
have difficulty in remembering and 
accessing services such as cervical 
screening (McKnight et al, 2006).
In the authors’ experience, well-
being nurses are able to provide 
counselling, brief interventions, 
solution-focused therapy, motivational 
interviewing, cognitive behavioural 
therapy (CBT), and psychosocial 
interventions to increase motivation 
and prevent relapse. They also help in 
addressing social problems including 
family issues, housing and employment. 
This is all with the aim of forming 
relationships, improving concordance 
and changing behaviours. 
Holistically, they manage every 
aspect of their clients’ needs in 
collaboration with many other services. 
The integration of well-being nurses 
into the management of IV drug users 
at WISMS has ensured that the care 
of leg ulceration is not overlooked 
or seen as a separate entity, where 
the patient would have to make 
separate appointments to see a 
health practitioner who specialised 
in that area. Before the introduction 
of the new care pathway, the well-
being nurses had been experiencing 
difficulties in accessing or providing 
this specialist area of care, as they felt 
inadequately skilled to provide leg 
ulcer management. Initially they sought 
support from community nursing 
teams, but this became problematic as 
many of the patients were not currently 
Treatments programmes 
must be tailored not only 
to treat the venous leg 
ulcer, but also to improve 
general and mental health 
and improve long-term 
outcomes both for the 
individual and the family. 
policy and practice. It concluded that 
effective treatment of the parent can 
have major benefits for the child, while 
also improving the quality of life for 
families and carers.
Treatment programmes
Treatments programmes for IV drug 
abusers suffering with venous leg 
ulcers should be tailored both to treat 
the ulcer and their general and mental 
health, thereby improving long-term 
outcomes for both the individual and 
their family. Wound drop-in centres 
have been developed to target 
homeless patients and/or patients with 
a history of drug dependency; these 
have been proven to be successful 
in terms of wound healing and 
improving access to services (Finnie 
and Nicholson, 2002). However, 
these services are often provided by 
nurses whose main area of speciality 
is wound management, rather than 
substance misuse. Within Wakefield 
Integrated Substance Misuse Service 
(WISMS), a new model of working 
has been implemented based around 
the well-being model, where service 
users work with registered general 
nurses and registered mental health 
nurses, who coordinate their often 
complex management programme 
and work in collaboration with many 
other services. The well-being model 
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registered with a general practitioner. 
The well-being nurses progressed to 
contacting the vascular nursing service 
within secondary care to provide 
the support and education that they 
required. 
Programme of education 
A programme of education and 
training was developed and 
undertaken by the well-being nurses 
relating to leg ulcer management. 
The team received training on wound 
management from the vascular nursing 
team, together with product selection 
and leg ulcer management including 
assessment, diagnosis and appropriate 
treatment. It was decided by the 
vascular nursing team not to train 
the well-being nurses in compression 
bandaging, as this requires intensive 
education and training (Stephen-
Hayes, 2006), plus they felt that they 
would not see the required volume 
of patients who needed bandaging to 
maintain their competency. Therefore, 
the decision was taken to provide 
the therapeutic levels of compression 
needed to treat venous ulceration 
by using compression hosiery kits, as 
these provide a sustained graduated 
compression that is determined by the 
manufacturing process (Thomas and 
Fram, 2003; World Union of Wound 
Healing Societies [WUWHS], 2008), 
not the individual. The well-being 
nurses were taught how to measure, 
apply and care for hosiery and were 
educated on how to examine the limb 
for any signs of skin damage. 
Additional advantages of using 
hosiery kits were that the patients 
had freedom of choice regarding 
footwear and clothing, as they were 
not restricted by the bulkiness of 
bandages. Patients were able to apply 
and remove their hosiery enabling 
them to take control of their care, 
which in turn encourages ownership 
and ultimately aids concordance (Coull 
and Clark, 2005). 
Using hosiery kits instead of 
compression bandaging could limit 
the type of ulcers that the well-being 
team could treat, as hosiery may not 
be suitable to manage highly exuding 
ulcers. Such ulcers may require bulky 
primary dressings to control the 
exudate, making application of hosiery 
difficult, or could even result in uneven 
pressure on the leg (Anderson, 2008). 
talcum powder, sanitary towels, babies’ 
nappies, and hand towels. They were 
thus given advice to seek professional 
help rather than treat the ulcer 
themselves. In the authors’ experience 
from working at WISMS, the majority 
of patients do not dress their ulcers, 
preferring to leave them exposed to 
the air, drying the wound bed naturally. 
Following the education and 
training programme, the well-being 
nurses still had reservations about 
performing ar terial assessment and 
ankle brachial pressure index (ABPI) 
measurement, as they believed that 
they would not have the need to 
perform the assessment frequently 
enough to ensure competent practice. 
This was considered in the design of 
the new care pathway by the well-
being nurses in collaboration with the 
vascular nurse team (Figure 1). 
Initial interventions were 
concerned with gaining and 
maintaining contact of the client with 
the well-being team. Once contact 
was established, an appointment 
would be made for the client to be 
seen by the vascular nurse team, in 
the environment most appropriate 
for the client. Ideally, clients would 
attend the vascular nurse outpatient 
Figure 1. Flow diagram of care pathway (VNS = vascular nurse specialist; WBN = well-being nurse).
Well-being nurse 
assessment 
Patient engaging?
Improving after 
6–8 weeks
Review by 
VNS/repeat 
assessment
VNS assessment 
ABPI, diagnosis, 
treatment
Patient management 
by WBN
If healed assessment 
of corrective venous 
insufficiency
WBN to minimise 
harm increase 
engagement
Continued WBN 
management
Healed or 
three months since 
last assessment
Yes No
No
Yes
Client pathway
... often this patient 
group have problems 
with trust, stigma and 
anxiety disorders, or are 
simply unable to attend 
appointments because 
they have no transport or 
money to physically get to 
the hospital. 
This was a limitation of the care 
pathway being developed, as it was 
initially felt by the vascular nursing 
team that many of the ulcers to be 
treated would be highly exuding. 
However, in the authors’ 
experience to date, this has not been 
the case, as the majority of ulcers 
experienced by this patient group 
have been dry with minimal exudate. 
Many patients are self-caring, finding 
their own ways of managing the ulcer 
and controlling the exudate. Many 
of the clients have ‘dried out’ their 
ulcers by various methods including 
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clinic independently. However, often 
this patient group have problems with 
trust, stigma and anxiety disorders, 
or are simply unable to attend 
appointments because they have no 
transport or money to physically get 
to the hospital. In these cases, the 
well-being nurses assessed the clients 
to decide which would be the best 
location for the assessment to be 
performed. The options included the 
well-being nurses collecting the patient 
and bringing them to the outpatient 
clinic, or the vascular nursing team 
visiting the WISMS clinic. On occasions, 
especially when the clients had severe 
anxiety issues, assessments were 
performed in the patients’ homes. 
Following the vascular assessments 
and recommendation of treatment 
plan, the patients’ ongoing care was 
delivered by the well-being nurses. 
The well-being nurses, being 
independent or supplementary 
prescribers and as a result of their 
recent training, were able to prescribe 
wound products and hosiery kits and 
reviewed the patients on a regular 
basis, altering treatment programmes 
as necessary. If at any point the well-
being nurses were concerned, a 
review appointment was arranged 
with the vascular nursing team. The 
well-being nurses encouraged the 
patients to become active partners 
with their wound care as well as their 
drug treatment; this is essential when 
dealing with substance misuse and is 
associated with good outcomes (DH, 
2007). 
Multidisciplinary working 
The DH (2007) suggest that many 
drug misusers have a myriad of 
health and social problems that often 
require interventions from a range 
of providers. Joint working across 
health and social care is therefore 
a key feature of effective treatment. 
Wheatley (2007) reported the 
benefits of collaborative working with 
consultant nurses for the homeless, 
in building relationships and providing 
education and training to enable 
nurses with expert knowledge 
of this specialised client group to 
provide optimum leg ulcer care. 
This new pathway goes fur ther to 
provide a formal arrangement of true 
collaborative working led by the well-
being team.
Scottish Intercollegiate Guidelines 
Network [SIGN], 2010), but when 
assessing and treating this challenging 
patient group of IV drug users, 
pathways need to be modified and 
delivered by the most appropriate 
practitioner to ensure effective 
treatment. Vascular nursing teams, 
tissue viability nurses and community 
nursing teams are often experts in leg 
ulcer management, but lack skills and 
knowledge relating to substance misuse. 
The well-being nurses have the skills, 
knowledge and access to supporting 
services to address the well-being 
needs of their patients. Healing of 
the leg ulcer is only one part of this 
patient group’s journey, with the final 
destination being overcoming drug 
dependency. This is often extremely 
difficult, as it not only involves tackling 
the addiction, but also embarking on 
and maintaining major lifestyle changes 
— this is where the unique skills and 
knowledge of the well-being nurses play 
an essential part. 
The design and implementation 
of a intercollaborative care pathway 
for this specific patient group ensures 
primary and secondary care creates a 
seamless service, providing best quality 
care that addresses the true holistic 
needs of the patients.
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  Key points
 8 Leg ulceration is known to be 
a consequence of intravenous 
(IV) drug use.
 8 Patients with a history of 
injection drug use have many 
risk factors for developing 
chronic venous insufficiency.
 8 Drug users have a wider 
range of health problems 
than members of the general 
population, and have higher 
rates of mental health disorders.
	8 Dependency to a substance 
dominates patients’ lives and 
can place an enormous strain 
on the family of drug misusers, 
including the children of drug 
using parents.
	8 Treatments programmes must 
be tailored not only to treat 
the venous leg ulcer, but also 
to improve general and mental 
health and improve long-term 
outcomes.
	8 Joint working across health and 
social care is key feature of 
effective treatment.
